We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Noninvasive Hemoglobin Sensor Assists Anemia Screening

By HospiMedica International staff writers
Posted on 23 Jul 2012
A wireless, noninvasive hemoglobin (Hb) measurement system uses an optical sensor for anemia monitoring, hemorrhage detection, and predonation screening.

The Glasswing Hb measurement system is based on proprietary SpectOLight technology, which provides a quick, accurate, and painless measurement of the donor’s blood constituents, while greatly improving donors’ comfort, eliminating infection risk, and providing the medical staff with accurate readings and immediate results. More...
The device is designed for use in environments such as perioperative and critical care units, emergency medicine, blood donation facilities, women’s health, primary care physician’s office, and homecare.

The portable, wireless device operates via rechargeable batteries using a ring-shaped sensor fitted on the donor’s finger and applies pressure, temporarily occluding local blood flow. Optical elements in the sensor then perform a sensitive measurement of the light transmitted through the finger. Hb measurements obtained by the system in multiple applications have shown accurate performance, compared with the gold standard invasive reference values. The system also enables on-line storage and download of data, real-time communication with electronic medical records (EMRs) in the hospital or blood donation centers, and communication with other digital data devices and printers. The Glasswing Hb measurement system is a product of OrSense (Nes Ziona, Israel).

“We are proud to introduce Glasswing, our improved revolutionary solution for noninvasive measurements of hemoglobin,” said Lior Ma'ayan, CEO of OrSense. “OrSense's noninvasive solution improves anemia screening and monitoring by eliminating pain, reducing infection risk, and enabling a simple and fast diagnosis. Our noninvasive system was found to be environmentally friendly, safe, fast and easy to use by the operating staff, and is already in use in multiple blood donation centers and blood banks in around the world, improving donor and patient safety and care.”

Hb measurements are usually performed using capillary blood obtained by finger pricking, which is sent to the lab for results.

Related Links:

OrSense



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.